RNAi Research and Transfection Services
RNA interference (RNAi) has become a foundational technology in functional genomics, therapeutic development, and disease modeling. Through siRNA and shRNA-mediated gene silencing, RNAi enables researchers to selectively suppress gene expression in a broad range of biological systems. Whether used in transient transfections, stable cell lines, or in vivo studies, RNAi is a highly adaptable platform with diverse applications in cancer research, drug discovery, and gene function analysis.
This section of the website introduces a series of advanced RNAi research methods and services. Each subpage explores a specific topic in-depth—from delivery technologies and screening platforms to quantitative validation strategies. The following topics provide a complete view of RNAi applications in both in vitro and in vivo contexts.
In Vivo siRNA Delivery and Tissue Targeting (In Vivo RNAi)
In Vivo siRNA Delivery and Tissue Targeting (In Vivo RNAi) uses advanced lipid or nanoparticle systems to protect siRNA and deliver it specifically to target tissues in live organisms. This approach overcomes biological barriers to enable effective gene silencing in complex disease models.
Generation of Tetracycline-inducible RNAi Gene Knockdown Cell Lines
Generation of Tetracycline-inducible RNAi Gene Knockdown Cell Lines enables controlled gene silencing through inducible shRNA expression, allowing temporal regulation of knockdown to study dynamic biological processes with reduced toxicity.
PCR Cloning: DNA Vector Construction (shRNA)
PCR Cloning: DNA Vector Construction (shRNA) involves designing and assembling DNA plasmids encoding shRNA sequences, which serve as templates for stable and efficient gene knockdown in cell models.
RNAi Manufacturing and CRO Services
RNAi Manufacturing and CRO Services offer custom synthesis, formulation, and delivery support for RNAi reagents, enabling scalable, high-quality gene silencing solutions tailored to research and preclinical needs.
RNAi Screen Pathway Analysis: siRNA and microRNA
RNAi Screen Pathway Analysis: siRNA and microRNA uses targeted RNAi libraries to dissect gene networks and signaling pathways, identifying key regulators and potential therapeutic targets.
Quantitation sh/siRNA-induced Knockdown by qRT-PCR and WB
Quantitation sh/siRNA-induced Knockdown by qRT-PCR and WB measures mRNA and protein levels to validate gene silencing efficiency and correlate knockdown with biological effects.
Genome-wide siRNA and microRNA High-throughput Screens
Genome-wide siRNA and microRNA High-throughput Screens enable large-scale functional genomics by systematically silencing thousands of genes or microRNAs to identify regulators of cellular phenotypes.
Stable RNAi Cell Line Generation: Stable Gene Knockdown
Stable RNAi Cell Line Generation: Stable Gene Knockdown produces cell lines with long-lasting gene suppression via integrated shRNA constructs for in-depth functional studies.
siRNA Transfection and RNAi Cell-based Library Screening
siRNA Transfection and RNAi Cell-based Library Screening combine optimized delivery with high-throughput screening to rapidly identify gene functions in various cellular processes.
siRNA Liposome Encapsulation Service
siRNA Liposome Encapsulation Service packages siRNA into lipid vesicles to enhance stability, uptake, and tissue targeting for improved delivery in vitro and in vivo.
Transient (siRNA) and Stable (shRNA) Transfection Services
Transient (siRNA) and Stable (shRNA) Transfection Services provide flexible gene silencing options for short-term knockdown or long-term suppression depending on experimental needs.
This page serves as a central resource for navigating advanced RNAi technologies and services. Each subpage provides the scientific depth required for researchers designing gene silencing experiments across cell-based systems, animal models, and high-throughput platforms. For specialized applications, validated protocols, and customized RNAi solutions, professional support is available through dedicated services described within these sections.